R.H. Bluestein & Co’s Exact Sciences EXAS Stock Holding History

R.H. Bluestein & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$202K	Sell	6,227 -165	-3%	-$6.8K	0.01%	323
2022 Q2	$252K	Sell	6,392 -258	-4%	-$13.8K	0.02%	295
2022 Q1	$465K	Buy	6,650 +2,135	+47%	+$156K	0.02%	207
2021 Q4	$351K	Sell	4,515 -2,975	-40%	-$263K	0.01%	280
2021 Q3	$715K	Buy	7,490 +555	+8%	+$58.6K	0.03%	158
2021 Q2	$862K	Buy	+6,935	New	+$828K	0.03%	145
2020 Q3	–	Sell	-3,899	Closed	-$339K	–	357
2020 Q2	$339K	Sell	3,899 -57,812	-94%	-$4.62M	0.02%	209
2020 Q1	$3.58M	Buy	61,711 +58,811	+2,028%	+$4.77M	0.3%	49
2019 Q4	$268K	Buy	+2,900	New	+$255K	0.01%	292
2019 Q3	–	Sell	-3,350	Closed	-$395K	–	340
2019 Q2	$395K	Buy	+3,350	New	+$338K	0.02%	181
2015 Q3	–	Sell	-10,500	Closed	-$312K	–	309
2015 Q2	$312K	Buy	+10,500	New	+$264K	0.02%	252

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

R.H. Bluestein & Co's EXAS Position: Q3 2022 in Review

R.H. Bluestein & Co reduced its Exact Sciences (EXAS) stake by 2.6% in Q3 2022, selling an estimated $6.8K and leaving 6,227 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #323.

R.H. Bluestein & Co first reported a position in EXAS in Q2 2015 and has held it in 11 quarters since. The position peaked at $3.58M in Q1 2020. 479 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

R.H. Bluestein & Co held 6,227 shares of Exact Sciences worth $202K as of Q3 2022.
R.H. Bluestein & Co sold 165 Exact Sciences shares in Q3 2022, an estimated $6.8K.
Exact Sciences made up 0.01% of R.H. Bluestein & Co's portfolio in Q3 2022, its #323 holding.
R.H. Bluestein & Co first reported a position in Exact Sciences in Q2 2015 and has held it in 11 quarters since.
R.H. Bluestein & Co's Exact Sciences position peaked at $3.58M in Q1 2020.
479 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.